🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Inspiring talk by Dr. Wulff from KU Cancer Center on ADCs in #UrothelialCarcinoma. From ADCs transforming UC treatment, novel HER2-targeted ADCs offering hope. As the field grows, access #equity will determine the true impact of these advances. Community challenges and real world

#ASCO25 attendees: Check out the Quality Care/Health Services Research Poster Session at 1:30 pm featuring “Association of MammaPrint and clinical outcomes by race among 5000 individuals with HR+HER2- early stage breast cancer enrolled in FLEX” with Dr. Priyanka Sharma.

If you’re attending #ASCO25, check out Poster Session - Prevention, Risk Reduction, and Genetics in Hall A from 1:30-4:30 pm featuring “Acolbifene vs tamoxifen for breast cancer prevention in premenopausal women at high risk for breast cancer.”

Antibody-drug conjugates in #UrothelialCarcinoma: Bridging innovation and community practice. Presentation by Elizabeth Wulff-Burchfield, MD KU Cancer Center. #ASCO25 written coverage by Rashid K. Sayyid USC > bit.ly/4jpW9YD ASCO

#ASCO25 Poster presentation on Tarlatamab in SCLC. Nikhil Vojjala, MD summarises below 👇👏🏼Prakash Neupane KU Cancer Center

#ASCO25, the day is winding down, but we’re not done yet! Don’t miss the Rapid Oral Abstract Session in Room E450a at 9:12 pm to view “Efficacy and safety of first-line ibrutinib plus venetoclax in patients with mantle cell lymphoma (MCL) who were older or had TP53 mutations in

Hello #ASCO25 attendees! At 9 am, head over to Hall A where Muhammad Umair Mushtaq (Abu Mikael) and the KU Cancer Center team are presenting “Allogeneic hematopoietic stem cell transplantation in T-cell acute lymphoblastic leukemia adults in complete remission: A systematic review and meta-analysis.”

Don’t miss the KU Cancer Center team from 9-noon in Hall A presenting “Clinical outcomes of cytomegalovirus infection among patients receiving chimeric antigen receptor T cell therapy.” #ASCO25 #KUBloodCancer Al-Ola A Abdallah MD (USMIRC) Nausheen Ahmed MD

#ASCO25 – Also happening from 9-noon, Muhammad Umair Mushtaq (Abu Mikael) and the KU Cancer Center team are presenting “Factors associated with outcomes following reduced intensity conditioning haploidentical hematopoietic cell transplantation in acute myeloid leukemia.” #KUBloodCancer #AML

Be sure to check out the #ASCO25 Rapid Oral Abstract Session in Room S406 where Anup Kasi MD MPH is presenting “Durable responses in ICI-refractory or acquired resistance: Phase 2 study of NP-G2-044 combined with anti-PD-1 therapy.”

ASCO #ASCO25 . Visit Poster 209, which builds on our prior work on optimizing monitoring time post #CART infusion. 2 weeks may be the sweet spot for most approved products ! Bristol Myers Squibb KU Cancer Center

Visit our poster #ASCO25 Nikhil Vojjala, MD .on SPM in CART

Don’t miss the Clinical Science Symposium at #ASCO25, starting at 5 pm in the Arie Crown Theater, where Shane Stecklein, MD, PhD and the KU Cancer Center team is presenting “Assessment of ctDNA somatic homologous recombination deficiency (HRD) in triple-negative breast cancer (TNBC) from

Let’s show the world what life after cancer looks like! Help us celebrate National Cancer Survivors Day. #NCSD2025 #CelebrateLife

Today is #NationalCancerSurvivorsDay. Throughout the years, I’ve been so inspired by those who have fought so valiantly and were victorious with their fight against #cancer. However, no one hit harder for me than Breast Care Center at Liberty Hospital Manager and now dear person

#ASCO25 posters. Our rising star hospitalist Muhammad Atif Khan MD presenting database study on #CMV and #CART. We highlight the serious impact of CMV infection in CAR-T recipients, ⬆️ mortality, ⬆️ hospital stays, high association with ICANS/ neuro complications. Findings support need

Happy Monday #ASCO25! Check out Dr. Priyanka Sharma and the KU Cancer Center team presenting “Results of a phase I study of alpelisib and sacituzumab govitecan (SG) in patients with HER2-negative metastatic breast cancer (MBC)” starting at 9 am in Hall A. #MBC #KUWCC

If you’re attending #ASCO25, don’t miss the Breast Cancer-Metastatic Poster Session in Hall A from 9-noon, where the KU Cancer Center team is sharing “Standard-dose vs fixed-dose capecitabine in patients with advanced gastrointestinal and metastatic breast cancer.” #MBC #KUWCC

Also happening from 9-noon, join the Breast Cancer—Local/Regional/Adjuvant Poster Session, where Dr. Priyanka Sharma and Shane Stecklein, MD, PhD are presenting “Association of ImPrintTN signature with survival outcomes by race in basal-type triple negative breast cancer (TNBC): FLEX

CMV reactivation in #CART recipients: ⬆️ mortality, relapse, & NRM. 🔴 High risk: BCMA-CAR-T, prior allo-HSCT, severe CRS/ICANS. 🔍 #ASCO25 Faiza Humayun Khan Muhammad Atif Khan MD KU Cancer Center